REPORT HIGHLIGHT
High end cellomics market size was valued at USD 3,360.8 Million in 2022, expanding at a CAGR of 11.9% from 2023 to 2030.
High-end cellomics is a sophisticated and advanced approach to cell analysis and imaging that integrates cellular biology and high-resolution microscopy. Additionally, examines the function, behavior, and structure of cells at a high level of detail, it includes cutting-edge technologies and specialized tools. It helps researchers in learning deep insights into cellular interactions, cellular processes, and the underlying mechanisms of diseases.
High End Cellomics Market - Market Dynamics:
- Application in drug discovery, personalized medicine, and technological advancements fueling the market growth
- In drug discovery and development, the application of high-end cellomics is contributing to market growth as pharmaceutical companies are increasingly involving high-throughput cellomics and high-content screening for lead compound toxicity and identification testing. Moreover, in the development of personalized therapies by identifying specific biomarkers and drug targets, cellomics supports the development of personalized therapies. To make drug discovery more effective, focused, and rapid, companies are also using patient-derived spheroids, organoids, and other in-vitro models in cellomics early in preclinical tests. However, high capital and operational costs for advanced high-end cellomics instruments are likely to restrain the high-end cellomics market growth. Moreover, significant technological advancements in cellomics techniques are projected to drive the growth of the high-end cellomics market. Advanced high-resolution microscopes, innovative imaging software, and enhanced workflow cytometry systems are being manufactured by companies to allow more in-depth study of cell morphology, behavior, and functionality. Thus, these advanced technologies offer researchers equipment to gain valuable insights as a result boosting the high-end cellomics market growth.
High End Cellomics Market - Key Insights:
- As per the analysis shared by our research analyst, the global high end cellomics market is estimated to grow annually at a CAGR of around 11.9% over the forecast period (2023-2030)
- The high end cellomics industry is projected to grow at a significant rate due to the rising use of organ-on-a-chip models in cellomics research
- Based on product type segmentation, instruments was predicted to show maximum market share in the year 2022
- Based on application segmentation, cell identification was the leading type in 2022
- Increasing incidence of chronic and infectious diseases such as autoimmune disorders, cancer, and COVID-19 is fueling high-end cellomics market growth
High End Cellomics Market- Segmentation Analysis:
- The global high end cellomics market is segmented on the basis of product type, application, end user, technology, and region.
- The market is divided into four categories based on product type: software & services, consumables, reagents, instruments, and others. The instruments segment is accounted to possess the largest revenue share. It is important in-depth cellular analysis, driving advancements in several fields including disease research, personalized medicine, and disease research. Additionally, continuous innovation is likely to shape the future of this segment.
- The market is divided into five categories based on application: cell analysis, cell viability, cell identification, cell engineering, target identification & validation, and others. The cell identification segment is witnessing to hold the largest market share. It includes classifying cells into particular categories or types based on the extracted features. Machine learning algorithms, such as random forests, neural networks, and support vector machines (SVM) can be utilized for this purpose.
High End Cellomics Market - Geographical Insights:
The high-end cellomics market is geographically extensive and includes North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is projected to be the largest market during the forecast period due to the high healthcare expenditure, growing research on cellomics, and presence of key players. Europe is likely to be the second-largest market for high-end cellomics market. The growth of the market is attributed to the rising incidence of chronic diseases and rising research funding. The Asia Pacific is accounted to be the fastest-growing market owing to its well-established healthcare infrastructure, focus on precision medicine, and growing biopharma sector.
High End Cellomics Market- Competitive Landscape:
Increasing investments and R&D spending in life sciences globally has positively impacted the high-end cellomics market. Private and government funding in translational medical research and fundamental cell biology has increased. These offer resources for cellomics research and raise its use in biomedical and clinical applications. Moreover, strategic partnerships and collaborations between research organizations, academic institutions, and market players are expanding the market reach and fostering innovation. For instance, in February 2023, Agilent Technologies Inc. introduced its new NovoExpress software that introduced integrated compliance equipment for NovoCyte flow cytometer systems. The compliance-enabling functionality enables users to meet regulatory standards.
Recent Developments:
For instance, in August 2022, by life science group Albumedix Ltd., a renowned leader in recombinant human albumin-based solutions, was acquired by the life science group Sartorius, a global leader in laboratory and bioprocessing technology. Through this acquisition, Albumedix and Sartorius enlarge their solution space with synergetic competencies and complementary technologies, to deliver science-enabled solutions for the entire advanced therapy value chain.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HIGH END CELLOMICS MARKET KEY PLAYERS
- BD
- Miltenyi Biotec
- Luminex
- Fluidigm
- GE Healthcare
- Thermo Fisher Scientific
- Nanostring Technologies
- Bio-Techne
- Danaher
- Bionano Genomics
- PerkinElmer
- Sphere Fluidics
- Berkeley Lights
- Bio-Rad Laboratories
- Celsee
- Agilent Technologies
- Illumina
- Merck KGaA
- 10x Genomics
- Bruker
GLOBAL HIGH END CELLOMICS MARKET, BY PRODUCT TYPE
- Software & Services
- Consumables
- Reagents
- Instruments
- Others
GLOBAL HIGH END CELLOMICS MARKET, BY APPLICATION
- Cell Analysis
- Cell Viability
- Cell Identification
- Cell Engineering
- Target Identification & Validation
- Others
GLOBAL HIGH END CELLOMICS MARKET, BY END USER
- Contract Research Organizations
- Academic & Research Institutes
- Hospitals & Diagnostic Laboratories
- Biotechnology & Pharmaceutical Companies
- Others
GLOBAL HIGH END CELLOMICS MARKET, BY TECHNOLOGY
- Mass Spectrometry
- Single-cell Genomics
- Microscopy
- Flow Cytometry
- Next Generation Sequencing
- Others
GLOBAL HIGH END CELLOMICS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA